ZNF501
gene geneOn this page
Also known as MGC21738
Summary
ZNF501 (zinc finger protein 501, HGNC:23717) is a protein-coding gene on chromosome 3p21.31, encoding Zinc finger protein 501 (Q96CX3). May be involved in transcriptional regulation.
Enables sequence-specific double-stranded DNA binding activity. Involved in Golgi organization. Located in nucleus.
Source: NCBI Gene 115560 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 49 total
- MANE Select transcript:
NM_001258280
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23717 |
| Approved symbol | ZNF501 |
| Name | zinc finger protein 501 |
| Location | 3p21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC21738 |
| Ensembl gene | ENSG00000186446 |
| Ensembl biotype | protein_coding |
| Entrez | 115560 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 8 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000396048, ENST00000484233, ENST00000486486, ENST00000620116, ENST00000927004, ENST00000927005, ENST00000927006, ENST00000927007, ENST00000927008, ENST00000954775
RefSeq mRNA: 2 — MANE Select: NM_001258280
NM_001258280, NM_145044
CCDS: CCDS2720
Canonical transcript exons
ENST00000620116 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001179362 | 44731476 | 44731560 |
| ENSE00001549941 | 44734197 | 44737083 |
| ENSE00001919274 | 44729635 | 44730015 |
Expression profiles
Bgee: expression breadth ubiquitous, 132 present calls, max score 85.21.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.6757 / max 88.6392, expressed in 1286 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 36343 | 3.6757 | 1286 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.21 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.29 | gold quality |
| ventricular zone | UBERON:0003053 | 79.59 | gold quality |
| ganglionic eminence | UBERON:0004023 | 79.46 | gold quality |
| cortical plate | UBERON:0005343 | 79.23 | gold quality |
| calcaneal tendon | UBERON:0003701 | 78.56 | gold quality |
| endometrium | UBERON:0001295 | 74.45 | gold quality |
| islet of Langerhans | UBERON:0000006 | 73.23 | gold quality |
| corpus callosum | UBERON:0002336 | 72.55 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 72.53 | gold quality |
| stromal cell of endometrium | CL:0002255 | 72.23 | gold quality |
| muscle tissue | UBERON:0002385 | 71.23 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 71.13 | gold quality |
| colonic epithelium | UBERON:0000397 | 71.06 | gold quality |
| placenta | UBERON:0001987 | 70.35 | gold quality |
| urinary bladder | UBERON:0001255 | 70.11 | gold quality |
| pancreas | UBERON:0001264 | 69.50 | gold quality |
| body of uterus | UBERON:0009853 | 69.43 | gold quality |
| right coronary artery | UBERON:0001625 | 69.24 | gold quality |
| fallopian tube | UBERON:0003889 | 69.24 | gold quality |
| myometrium | UBERON:0001296 | 69.19 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 69.17 | gold quality |
| lower esophagus | UBERON:0013473 | 69.12 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 69.08 | gold quality |
| lymph node | UBERON:0000029 | 68.88 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 68.50 | gold quality |
| left coronary artery | UBERON:0001626 | 68.34 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 68.06 | gold quality |
| popliteal artery | UBERON:0002250 | 67.86 | gold quality |
| tibial artery | UBERON:0007610 | 67.84 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.85 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
106 targeting ZNF501, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
| HSA-MIR-548J-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548W | 99.94 | 71.24 | 3488 |
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 501 — Q96CX3 (reviewed: Q96CX3)
Alternative names: Zinc finger protein 52
All UniProt accessions (1): Q96CX3
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation. Essential for Golgi structural integrity.
Subcellular location. Nucleus. Nucleolus.
Induction. Up-regulated by Golgi stress-inducing agent nigericin.
Miscellaneous. May be due to exon skipping.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q96CX3-1 | 1 | yes |
| Q96CX3-2 | 2 |
RefSeq proteins (2): NP_001245209, NP_659481 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (13 total): zinc finger region 9, sequence variant 2, chain 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96CX3-F1 | 90.88 | 0.89 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 36 (showing top):
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_GOLGI_ORGANIZATION, GOCC_NUCLEOLUS, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, FIGUEROA_AML_METHYLATION_CLUSTER_3_UP, chr3p21, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CBX5_TARGET_GENES, DIDO1_TARGET_GENES, HES4_TARGET_GENES, HHEX_TARGET_GENES, SNIP1_TARGET_GENES, ZNF423_TARGET_GENES, ZNF561_TARGET_GENES
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), Golgi organization (GO:0007030)
GO Molecular Function (7): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), sequence-specific double-stranded DNA binding (GO:1990837), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (2): nucleus (GO:0005634), nucleolus (GO:0005730)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| transcription by RNA polymerase II | 1 |
| organelle organization | 1 |
| endomembrane system organization | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| transcription cis-regulatory region binding | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| double-stranded DNA binding | 1 |
| sequence-specific DNA binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
1680 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF501 | TRIM28 | Q13263 | 981 |
| ZNF501 | ZUP1 | Q96AP4 | 856 |
| ZNF501 | USP5 | P45974 | 819 |
| ZNF501 | UBB | P02248 | 811 |
| ZNF501 | YOD1 | Q5VVQ6 | 788 |
| ZNF501 | USP44 | Q9H0E7 | 773 |
| ZNF501 | OTUD7A | Q8TE49 | 740 |
| ZNF501 | ZPR1 | O75312 | 670 |
| ZNF501 | SETDB1 | Q15047 | 669 |
| ZNF501 | CRBN | Q96SW2 | 660 |
| ZNF501 | HDAC6 | Q9UBN7 | 653 |
| ZNF501 | UBA2 | Q9UBT2 | 647 |
| ZNF501 | PHF20 | Q9BVI0 | 638 |
| ZNF501 | NPLOC4 | Q8TAT6 | 568 |
| ZNF501 | ZFAND5 | O76080 | 558 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ZNF501 | THUMPD3 | psi-mi:“MI:0914”(association) | 0.530 |
| M | ZNF501 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ZNF501 | PCK1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (14): RPL26L1 (Affinity Capture-MS), RAD18 (Affinity Capture-MS), THUMPD3 (Affinity Capture-MS), ARIH1 (Affinity Capture-MS), ARIH1 (Affinity Capture-MS), RAD18 (Affinity Capture-MS), THUMPD3 (Affinity Capture-MS), RPL26L1 (Affinity Capture-MS), RAD18 (Affinity Capture-MS), THUMPD3 (Affinity Capture-MS), ARIH1 (Affinity Capture-MS), MRRF (Affinity Capture-MS), PCK1 (Affinity Capture-MS), ZNF501 (Affinity Capture-MS)
ESM2 similar proteins: O73694, P18712, P18717, P18719, P18720, P18721, P18722, P18724, P18727, P18730, P18731, P18732, P18734, P18735, P18738, P18740, P18741, P18742, P18743, P18744, P18750, P24399, P26634, P26635, P31507, P31508, P31509, Q01779, Q01792, Q01793, Q01797, Q01799, Q01800, Q01871, Q01872, Q02025, Q02026, Q02027, Q02034, Q02035
Diamond homologs: Q5RF70, Q96CX3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
49 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
386 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:44729661:GGACC:G | donor_gain | 0.9900 |
| 3:44729662:GACC:G | donor_gain | 0.9900 |
| 3:44729779:G:GT | donor_gain | 0.9900 |
| 3:44729779:G:T | donor_gain | 0.9900 |
| 3:44729786:G:GT | donor_gain | 0.9900 |
| 3:44731474:A:AG | acceptor_gain | 0.9900 |
| 3:44731475:G:GG | acceptor_gain | 0.9900 |
| 3:44729689:G:T | donor_gain | 0.9700 |
| 3:44729713:G:GT | donor_gain | 0.9600 |
| 3:44729857:A:T | donor_gain | 0.9600 |
| 3:44731475:GT:G | acceptor_gain | 0.9600 |
| 3:44729713:G:T | donor_gain | 0.9500 |
| 3:44729662:G:T | donor_gain | 0.9200 |
| 3:44729723:G:GG | donor_gain | 0.9200 |
| 3:44734196:G:C | acceptor_gain | 0.9200 |
| 3:44729921:GCAT:G | donor_gain | 0.9100 |
| 3:44730016:G:GG | donor_gain | 0.9100 |
| 3:44729650:G:T | donor_gain | 0.9000 |
| 3:44729719:CATG:C | donor_loss | 0.9000 |
| 3:44729720:ATGG:A | donor_loss | 0.9000 |
| 3:44729722:GGTG:G | donor_loss | 0.9000 |
| 3:44729723:GT:G | donor_loss | 0.9000 |
| 3:44729724:T:TG | donor_loss | 0.9000 |
| 3:44729725:GA:G | donor_loss | 0.9000 |
| 3:44729828:GCC:G | donor_gain | 0.9000 |
| 3:44729883:G:GT | donor_gain | 0.9000 |
| 3:44734196:GA:G | acceptor_gain | 0.9000 |
| 3:44734196:GAGA:G | acceptor_gain | 0.9000 |
| 3:44731475:GTGC:G | acceptor_gain | 0.8900 |
| 3:44734195:A:AG | acceptor_gain | 0.8900 |
AlphaMissense
1811 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:44734932:T:C | F171L | 0.996 |
| 3:44734934:T:A | F171L | 0.996 |
| 3:44734934:T:G | F171L | 0.996 |
| 3:44734680:T:C | F87L | 0.995 |
| 3:44734682:T:A | F87L | 0.995 |
| 3:44734682:T:G | F87L | 0.995 |
| 3:44734764:T:C | F115L | 0.995 |
| 3:44734766:T:A | F115L | 0.995 |
| 3:44734766:T:G | F115L | 0.995 |
| 3:44734848:T:C | F143L | 0.995 |
| 3:44734850:C:A | F143L | 0.995 |
| 3:44734850:C:G | F143L | 0.995 |
| 3:44735016:T:C | F199L | 0.995 |
| 3:44735018:C:A | F199L | 0.995 |
| 3:44735018:C:G | F199L | 0.995 |
| 3:44734798:G:C | R126P | 0.993 |
| 3:44735100:T:C | F227L | 0.992 |
| 3:44735102:C:A | F227L | 0.992 |
| 3:44735102:C:G | F227L | 0.992 |
| 3:44734709:T:A | H96Q | 0.991 |
| 3:44734709:T:G | H96Q | 0.991 |
| 3:44734961:T:A | H180Q | 0.990 |
| 3:44734961:T:G | H180Q | 0.990 |
| 3:44734783:T:C | L121P | 0.988 |
| 3:44734793:C:A | H124Q | 0.988 |
| 3:44734793:C:G | H124Q | 0.988 |
| 3:44734867:T:C | L149P | 0.988 |
| 3:44735184:T:C | F255L | 0.988 |
| 3:44735186:T:A | F255L | 0.988 |
| 3:44735186:T:G | F255L | 0.988 |
dbSNP variants (sampled 300 via entrez): RS1000138254 (3:44730570 C>T), RS1001049637 (3:44731680 T>G), RS1001092306 (3:44731641 G>A,T), RS1001544819 (3:44732051 G>A), RS1001656802 (3:44729854 A>G), RS1001919392 (3:44730144 C>G,T), RS1002333735 (3:44735515 T>C), RS1002520793 (3:44729042 G>A), RS1002638049 (3:44728415 G>T), RS1003058172 (3:44728486 G>A), RS1003473246 (3:44733592 G>A), RS1003561344 (3:44734693 C>G,T), RS1003619128 (3:44734269 T>C), RS1003641798 (3:44729999 A>G), RS1003982766 (3:44730874 A>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST008103_52 | Bipolar disorder | 3.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | decreases expression, affects cotreatment | 3 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| trichostatin A | decreases expression | 1 |
| avobenzone | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| clothianidin | decreases expression | 1 |
| dorsomorphin | decreases expression, affects cotreatment | 1 |
| bisphenol S | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | increases methylation, decreases methylation | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XW53 | HEK293 eGFP-ZNF501 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.